Osaic Holdings
CRMD icon

Osaic Holdings’s CorMedix CRMD Stock Holding History

Osaic Holdings’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.8K Buy
6,982
+2,106
+43% +$16.6K ﹤0.01% 5407
2026
Q1 		$33.1K Sell
4,876
-257,725
-98% -$1.91M ﹤0.01% 5512
2025
Q4 		$3.05M Buy
262,601
+215,554
+458% +$2.38M ﹤0.01% 1755
2025
Q3 		$572K Buy
47,047
+39,638
+535% +$479K ﹤0.01% 3325
2025
Q2 		$91.3K Sell
7,409
-3,370
-31% -$37.2K ﹤0.01% 4584
2025
Q1 		$66.4K Buy
10,779
+3,826
+55% +$39.6K ﹤0.01% 4496
2024
Q4 		$56.3K Buy
6,953
+196
+3% +$1.96K ﹤0.01% 4613
2024
Q3 		$54.6K Buy
6,757
+2,459
+57% +$13.3K ﹤0.01% 4678
2024
Q2 		$18.6K Buy
4,298
+140
+3% +$711 ﹤0.01% 5395
2024
Q1 		$17.6K Buy
4,158
+1,449
+53% +$5.03K ﹤0.01% 5436
2023
Q4 		$10.2K Sell
2,709
-940
-26% -$3.23K ﹤0.01% 5821
2023
Q3 		$13.5K Hold
3,649
– – ﹤0.01% 5764
2023
Q2 		$14.5K Hold
3,649
– – ﹤0.01% 5759
2023
Q1 		$15.1K Buy
3,649
+809
+28% +$3.31K ﹤0.01% 5738
2022
Q4 		$12K Hold
2,840
– – ﹤0.01% 5840
2022
Q3 		$8K Sell
2,840
-5,420
-66% -$22.6K ﹤0.01% 6112
2022
Q2 		$33K Sell
8,260
-9,290
-53% -$34.5K ﹤0.01% 5252
2022
Q1 		$96K Hold
17,550
– – ﹤0.01% 4621
2021
Q4 		$80K Hold
17,550
– – ﹤0.01% 4762
2021
Q3 		$82K Hold
17,550
– – ﹤0.01% 4702
2021
Q2 		$121K Buy
17,550
+100
+0.6% +$796 ﹤0.01% 4315
2021
Q1 		$174K Buy
17,450
+15,373
+740% +$162K ﹤0.01% 3867
2020
Q4 		$15K Buy
2,077
+1,000
+93% +$6.8K ﹤0.01% 5323
2020
Q3 		$6K Buy
1,077
+677
+169% +$3.4K ﹤0.01% 5486
2020
Q2 		$3K Hold
400
– – ﹤0.01% 5644
2020
Q1 		$1K Buy
+400
New +$2.26K ﹤0.01% 5818

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Osaic Holdings's CRMD Position: Q2 2026 in Review

Osaic Holdings increased its CorMedix (CRMD) stake by 43% in Q2 2026, buying an estimated $16.6K and bringing the position to 6,982 shares worth $54.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5407.

Osaic Holdings first reported a position in CRMD in Q1 2020 and has held it in 26 quarters since. The position peaked at $3.05M in Q4 2025. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Osaic Holdings held 6,982 shares of CorMedix worth $54.8K as of Q2 2026.
  • Osaic Holdings bought 2,106 CorMedix shares in Q2 2026, an estimated $16.6K.
  • CorMedix made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5407 holding.
  • Osaic Holdings first reported a position in CorMedix in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's CorMedix position peaked at $3.05M in Q4 2025.
  • 193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.